Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and related navigation with a blocked-access screen; this prevents viewing the study details on this page.SummaryDifference18%

- Check44 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a backend/software update with no substantive content changes.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor version update to the page or its documentation. The change does not reveal any user-facing content changes.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small platform update that does not alter study details.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page's revision label was updated to v3.6.3, representing a minor update to the page's documentation/versioning metadata.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.